| Metric | FY2025 | FY2024 |
|---|---|---|
| Cash and cash equivalents | $237.6M+2780.3% | $8.2M |
| Accounts receivable, net | $8.1M+304.5% | $2.0M |
| Disposable medical equipment supplies | $6.6M+99.8% | $3.3M |
| Prepaid expenses and other current assets | $3.1M+124.8% | $1.4M |
| Total current assets | $255.3M+1612.8% | $14.9M |
| Right-of-use assets | $2.1M-9.1% | $2.3M |
| Deposits | $2.0M+18.2% | $1.7M |
| Restricted cash | $334K+0.0% | $334K |
| Property and equipment, net | $34.8M+33.4% | $26.1M |
| Other long-term assets | $1.2M+90.0% | $607K |
| Total assets | $295.7M+543.6% | $45.9M |
| Accounts payable | $24.0M+0.3% | $23.9M |
| Accrued liabilities | $13.8M+52.3% | $9.1M |
| Operating lease liabilities, current portion | $187K | — |
| Total current liabilities | $38.0M+15.2% | $33.0M |
| Operating lease liabilities, net of current portion | $3.0M+14.9% | $2.6M |
| Warrant liabilities | $8.1M | — |
| Other long-term liabilities | $140K+84.2% | $76K |
| Long-term debt, net | $41.1M-3.4% | $42.5M |
| Total liabilities | $90.3M+15.5% | $78.2M |
| Redeemable preferred stock, $0.01 par value; 0 and 5,000,000 shares authorized as of April 30, 2025 and April 30, 2024, respectively; 0 and 177,110 shares issued and outstanding as of April 30, 2025 and April 30, 2024, respectively | $177.1M | — |
| Common stock, $0.01 par value; 5,000,000 shares authorized as of April 30, 2024; 105,808 shares issued and outstanding as of April 30, 2024. Common shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2025; 51,348,656 shares issued and outstanding as of April 30, 2025 | $51.3M+157.9% | $19.9M |
| Additional paid-in capital | $674.3M+280.6% | $177.1M |
| Accumulated deficit | -$520.2M-28.0% | -$406.4M |
| Total shareholders' equity (deficit) | $205.4M+198.1% | -$209.4M |
| Total liabilities and shareholders' equity (deficit) | $295.7M+543.6% | $45.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.